Corrigendum to: Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria (Journal of Applied Microbiology, (2015), 119, 3, (620-631), 10.1111/jam.12881);Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria

Journal of Applied Microbiology

Volumn 119, Issue 3, 2015, Pages 620-631

  Nakonieczna, A ^a   Cooper, C J ^b   Gryko, Romuald ^a  

^a Biological Threat Identification Countermeasure Center of General Karol Kaczkowski Military Institute of Hygiene and Epidemiology   (Poland)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Bacillus; Bacteriophage; Clostridium; Endolysin; Phage therapy

Indexed keywords

ANTIBIOTICS; BACILLUS CEREUS; BACTERIOLOGY; BACTERIOPHAGES;

ANTIBIOTICS RESISTANCE; BACILLUS CEREUS GROUPS; BACTERIAL INFECTIONS; EASTERN EUROPE; ENDOLYSIN; GRAM POSITIVE; PHAGE THERAPY; RELATIVE ABUNDANCE; SPECIFIC NATURE; SPORE-FORMING BACTERIA;

CLOSTRIDIUM;

ANTIBIOTIC AGENT; ENDOLYSIN; HYDROLASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; PROTEINASE;

ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; BACTERIOPHAGE; BACTERIUM; ENZYME ACTIVITY; RELATIVE ABUNDANCE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS CEREUS; BACTERIOPHAGE; CLOSTRIDIUM; GENUS; GRAM POSITIVE BACTERIUM; HUMAN; NONHUMAN; ANIMAL; BACTERIAL SPORE; BIOLOGICAL THERAPY; CHEMISTRY; DRUG EFFECTS; GRAM-POSITIVE BACTERIAL INFECTIONS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; VIROLOGY;

EUROPE;

BACILLUS (BACTERIUM); BACILLUS CEREUS GROUP; BACTERIA (MICROORGANISMS); CLOSTRIDIUM; POSIBACTERIA;

ANIMALS; BACTERIOPHAGES; BIOLOGICAL THERAPY; ENDOPEPTIDASES; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; SPORES, BACTERIAL;

EID: 84939565832     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.13896     Document Type: Erratum

References (101)

1. Abedon, S.T. (2012) Bacterial 'immunity' against bacteriophages. Bacteriophage 2, 50-54.
2. Abedon, S.T., Kuhl, S.J., Blasdel, B.G. and Kutter, E.M. (2011) Phage treatment of human infections. Bacteriophage 1, 66-85.
3. Abshire, T.G., Brown, J.E. and Ezzell, J.W. (2005) Production and validation of the use of gamma phage for identification of Bacillus anthracis. J Clin Microbiol 43, 4780-4788.
4. Ackermann, H.W. (2012) Prokaryote viruses studies by electron microscopy. Arch Virol 157, 1843-1849.
5. Ågren, J., Hamidjaja, R.A., Hansen, T., Ruuls, R., Thierry, S., Vigre, H., Janse, J., Sundström, A. et al. (2013) In silico and in vitro evaluation of PCR-based assays for the detection of Bacillus anthracis chromosomal signature sequences. Virulence 4, 671-685.
6. Barrangou, R. and van der Oost, J. (2015) Bacteriophage exclusion, a new defense system. EMBO J 34, 134-135.
7. Bennett, S.D., Walsh, K.A. and Gould, L.H. (2013) Foodborne disease outbreaks caused by Bacillus cereus, Clostridium perfringens, and Staphylococcus aureus - United States, 1998-2008. Clin Infect Dis 57, 425-433.
8. Bishop, A.H. (2014) Germination and persistence of Bacillus anthracis and Bacillus thuringiensis in soil microcosms. J Appl Microbiol 117, 1274-1282.
9. Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J.-P., Defraine, V., Michiels, J., Cenens, W. et al. (2014) Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob Agents Chemother 58, 3774-3784.
10. Callewaert, L., Walmagh, M., Michiels, C.W. and Lavigne, R. (2011) Food applications of bacterial cell wall hydrolases. Curr Opin Biotechnol 22, 164-171.
11. Ceuppens, S., Boon, N. and Uyttendaele, M. (2013) Diversity of Bacillus cereus group strains is reflected in their broad range of pathogenicity and diverse ecological lifestyles. FEMS Microbiol Ecol 84, 433-450.
12. Chanishvili, N., Chanishvili, T., Tediashvili, M. and Barrow, P.A. (2001) Phages and their application against drug-resistant bacteria. J Chem Technol Biotechnol 76, 689-699.
13. Doganay, M. and Metan, G. (2009) Human anthrax in Turkey from 1990 to 2007. Vector Borne Zoonotic Dis 9, 131-140.
14. Dubberke, E.R. and Olsen, M.A. (2012) Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55, S88-S92.
15. El-Arabi, T.F., Griffiths, M.W., She, Y.M., Villegas, A., Lingohr, E.J. and Kropinski, A.M. (2013) Genome sequence and analysis of a broad-host range lytic bacteriophage that infects the Bacillus cereus group. Virol J 10, 48.
16. Elbreki, M., Ross, R.P., Hill, C., O'Mahony, J., McAuliffe, O. and Coffey, A. (2014) Bacteriophages and their derivatives as biotherapeutic agents in disease prevention and treatment. J Viruses 2014, 20.
17. Fard, R.M.N., Barton, M.D. and Heuzenroeder, M.W. (2011) Bacteriophage-mediated transduction of antibiotic resistance in enterococci. Lett Appl Microbiol 52, 559-564.
18. Fenton, M., McAuliffe, O., O'Mahony, J. and Coffey, A. (2010) Recombinant bacteriophage lysins as antibacterials. Bioeng bugs 1, 9-16.
19. Fischetti, V.A. (2010) Bacteriophage endolysins: a novel anti-infective to control gram-positive pathogens. Int J Med Microbiol 300, 357-362.
20. Fischetti, V.A., Schuch, R. and Nelson, D. (2013) Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions. US Patent 8, 580, 553.
21. Fouts, D.E., Rasko, D.A., Cer, R.Z., Jiang, L., Fedorova, N.B., Shvartsbeyn, A., Vamathevan, J.J., Tallon, L. et al. (2006) Sequencing Bacillus anthracis typing phages gamma and cherry reveals a common ancestry. J Bacteriol 188, 3402-3408.
22. Ganz, H.H., Law, C., Schmuki, M., Eichenseher, F., Calendar, R., Loessner, M.J., Getz, W.M., Korlach, J. et al. (2014) Novel giant siphovirus from Bacillus anthracis features unusual genome characteristics. PLoS ONE 9, e85972.
23. Gervasi, T., Horn, N., Wegmann, U., Dugo, G., Narbad, A. and Mayer, M. (2014) Expression and delivery of an endolysin to combat Clostridium perfringens. Appl Microbiol Biotechnol 98, 2495-2505.
24. Gillis, A. and Mahillon, J. (2014) Prevalence, genetic diversity, and host range of tectiviruses among members of the Bacillus cereus group. Appl Environ Microbiol 80, 4138-4152.
25. Goh, S., Riley, T.V. and Chang, B.J. (2005) Isolation and characterization of temperate bacteriophages of Clostridium difficile. Appl Environ Microbiol 71, 1079-1083.
26. Goh, S., Ong, P.F., Song, K.P., Riley, T.V. and Chang, B.J. (2007) The complete genome sequence of Clostridium difficile phage ΦC2 and comparisons to ΦCD119 and inducible prophages of CD630. Microbiology 153, 676-685.
27. Goh, S., Hussain, H., Chang, B.J., Emmett, W., Riley, T.V. and Mullany, P. (2013) Phage ΦC2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains. MBio 4, e00840-13.
28. Golais, F., Hollý, J. and Vítkovská, J. (2013) Coevolution of bacteria and their viruses. Folia Microbiol 58, 177-186.
29. Goldfarb, T., Sberro, H., Weinstock, E., Cohen, O., Doron, S., Charpak-Amikam, Y., Afik, S., Ofir, G. et al. (2015) BREX is a novel phage resistance system widespread in microbial genomes. EMBO J 34, 169-183.
30. Granum, P.E. and Lund, T. (1997) Bacillus cereus and its food poisoning toxins. FEMS Microbiol Lett 157, 223-228.
31. Hanlon, G.W. (2007) Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 30, 118-128.
32. Hargreaves, K.R. and Clokie, M.R. (2014) Clostridium difficile phages: still difficult? Front Microbiol 5, 184.
33. Herpers, B. (2015) Endolysins: redefining antibacterial therapy. Future Microbiol 1, 309-311.
34. Heselpoth, R.D., Owens, J.M. and Nelson, D.C. (2015) Quantitative analysis of the thermal stability of the gamma phage endolysin PlyG: a biophysical and kinetic approach to assaying therapeutic potential. Virology 477, 125-132.
35. Hoffmaster, A.R., Ravel, J., Rasko, D.A., Chapman, G.D., Chute, M.D., Marston, C.K., De, B.K., Sacchi, C.T. et al. (2004) Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci USA 101, 8449-8454.
36. Horvath, P. and Barrangou, R. (2010) CRISPR/Cas, the immune system of bacteria and archaea. Science 327, 167-170.
37. Kikkawa, H., Fujinami, Y., Suzuki, S. and Yasuda, J. (2007) Identification of the amino acid residues critical for specific binding of the bacteriolytic enzyme of gamma-phage, PlyG, to Bacillus anthracis. Biochem Biophys Res Commun 363, 531-535.
38. Kikkawa, H.S., Ueda, T., Suzuki, S.-I. and Yasuda, J. (2008) Characterization of the catalytic activity of the γ-phage lysin, PlyG, specific for Bacillus anthracis. FEMS Microbiol Lett 286, 236-240.
39. Kong, M., Kim, M. and Ryu, S. (2012) Complete genome sequence of Bacillus cereus bacteriophage PBC1. J Virol 86, 6379-6380.
40. Kretzer, J.W., Lehmann, R., Schmelcher, M., Banz, M., Kim, K.P., Korn, C. and Loessner, M.J. (2007) Use of high-affinity cell wall-binding domains of bacteriophage endolysins for immobilization and separation of bacterial cells. Appl Environ Microbiol 73, 1992-2000.
41. Kropinski, A.M. (2006) Phage therapy - everything old is new again. Can J Infect Dis Med Microbiol 17, 297-306.
42. Lavigne, R., Briers, Y., Hertveldt, K., Robben, J. and Volckaert, G. (2004) Identification and characterization of a highly thermostable bacteriophage lysozyme. Cell Mol Life Sci 61, 2753-2759.
43. Lee, J.-H., Shin, H., Son, B. and Ryu, S. (2012) Complete genome sequence of Bacillus cereus bacteriophage BCP78. J Virol 86, 637-638.
44. Lee, J.-H., Shin, H., Son, B., Heu, S. and Ryu, S. (2013) Characterization and complete genome sequence of a virulent bacteriophage B4 infecting food-borne pathogenic Bacillus cereus. Arch Virol 158, 2101-2108.
45. Leggett, M.J., Mcdonnell, G., Denyer, S.P., Setlow, P. and Maillard, J.Y. (2012) Bacterial spore structures and their protective role in biocide resistance. J Appl Microbiol 113, 485-498.
46. Leggett, M.J., Schwarz, J.S., Burke, P.A., Mcdonnell, G., Denyer, S.P. and Maillard, J.-Y. (2015) Resistance to and killing by the sporicidal microbicide peracetic acid. J Antimicrob Chemother 70, 773-779.
47. Loc-Carrillo, C. and Abedon, S.T. (2011) Pros and cons of phage therapy. Bacteriophage 1, 111-114.
48. Loessner, M.J., Maier, S.K., Daubek-Puza, H., Wendlinger, G. and Scherer, S. (1997) Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. J Bacteriol 179, 2845-2851.
49. Loessner, M.J., Kramer, K., Ebel, F. and Scherer, S. (2002) C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol Microbiol 44, 335-349.
50. Low, L.Y., Yang, C., Perego, M., Osterman, A. and Liddington, R.C. (2005) Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem 280, 35433-35439.
51. Lund, B.M. and Peck, M.W. (2013) Clostridium botulinum. Guide to Foodborne Pathogens, 2nd edn. pp. 91-111. Oxford: John Wiley & Sons.
52. Mao, J., Schmelcher, M., Harty, W.J., Foster-Frey, J. and Donovan, D.M. (2013) Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme. FEMS Microbiol Lett 342, 30-36.
53. Mayer, M.J., Narbad, A. and Gasson, M.J. (2008) Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin. J Bacteriol 190, 6734-6740.
54. Mayer, M.J., Payne, J., Gasson, M.J. and Narbad, A. (2010) Genomic sequence and characterization of the virulent bacteriophage ϕCTP1 from Clostridium tyrobutyricum and heterologous expression of its endolysin. Appl Environ Microbiol 76, 5415-5422.
55. Mayer, M.J., Garefalaki, V., Spoerl, R., Narbad, A. and Meijers, R. (2011) Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range. J Bacteriol 193, 5477-5486.
56. Mayer, M.J., Gasson, M.J. and Narbad, A. (2012) Genomic sequence of bacteriophage ATCC 8074-B1 and activity of its endolysin and engineered variants against Clostridium sporogenes. Appl Environ Microbiol 78, 3685-3692.
57. Meader, E., Mayer, M.J., Steverding, D., Carding, S.R. and Narbad, A. (2013) Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system. Anaerobe 22, 25-30.
58. Meessen-Pinard, M., Sekulovic, O. and Fortier, L.-C. (2012) Evidence of in vivo prophage induction during Clostridium difficile infection. Appl Environ Microbiol 78, 7662-7670.
59. Mehta, K.K., Paskaleva, E.E., Azizi-Ghannad, S., Ley, D.J., Page, M.A., Dordick, J.S. and Kane, R.S. (2013) Characterization of AmiBA2446, a novel bacteriolytic enzyme active against Bacillus species. Appl Environ Microbiol 79, 5899-5906.
60. Miller, R.W., Skinner, E.J., Sulakvelidze, A., Mathis, G.F. and Hofacre, C.L. (2010) Bacteriophage therapy for control of necrotic enteritis of broiler chickens experimentally infected with Clostridium perfringens. Avian Dis 54, 33-40.
61. Minakhin, L., Semenova, E., Liu, J., Vasilov, A., Severinova, E., Gabisonia, T., Inman, R., Mushegian, A. et al. (2005) Genome sequence and gene expression of Bacillus anthracis bacteriophage Fah. J Mol Biol 354, 1-15.
62. Moeller, R., Raguse, M., Reitz, G., Okayasu, R., Li, Z., Klein, S., Setlow, P. and Nicholson, W.L. (2014) Resistance of Bacillus subtilis spore DNA to lethal ionizing radiation damage relies primarily on spore core components and DNA repair, with minor effects of oxygen radical detoxification. Appl Environ Microbiol 80, 104-109.
63. Morales, C., Oakley, B., Garrish, J., Siragusa, G., Ard, M. and Seal, B. (2012) Complete genome sequence of the podoviral bacteriophage ΦCP24R, which is virulent for Clostridium perfringens. Arch Virol 157, 769-772.
64. Naanwaab, C., Yeboah, O.-A., Kyei, F., Sulakvelidze, A. and Goktepe, I. (2014) Evaluation of consumers' perception and willingness to pay for bacteriophage treated fresh produce. Bacteriophage 4, e979662.
65. Nale, J.Y., Shan, J., Hickenbotham, P.T., Fawley, W.N., Wilcox, M.H. and Clokie, M.R. (2012) Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains. PLoS ONE 7, e37263.
66. Nariya, H., Miyata, S., Tamai, E., Sekiya, H., Maki, J. and Okabe, A. (2011) Identification and characterization of a putative endolysin encoded by episomal phage phiSM101 of Clostridium perfringens. Appl Microbiol Biotechnol 90, 1973-1979.
67. Negus, D., Burton, J., Sweed, A., Gryko, R. and Taylor, P.W. (2013) Poly-γ-d-glutamic acid capsule interferes with lytic infection of Bacillus anthracis by B. anthracis-specific bacteriophages. Appl Environ Microbiol 79, 714-717.
68. Oakley, B.B., Talundzic, E., Morales, C.A., Hiett, K.L., Siragusa, G.R., Volozhantsev, N.V. and Seal, B.S. (2011) Comparative genomics of four closely related Clostridium perfringens bacteriophages reveals variable evolution among core genes with therapeutic potential. BMC Genom 12, 282.
69. Oey, M., Lohse, M., Scharff, L.B., Kreikemeyer, B. and Bock, R. (2009) Plastid production of protein antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proc Natl Acad Sci USA 106, 6579-6584.
70. Park, J., Yun, J., Lim, J.-A., Kang, D.-H. and Ryu, S. (2012) Characterization of an endolysin, LysBPS13, from a Bacillus cereus bacteriophage. FEMS Microbiol Lett 332, 76-83.
71. Porter, C.J., Schuch, R., Pelzek, A.J., Buckle, A.M., Mcgowan, S., Wilce, M.C.J., Rossjohn, J., Russell, R. et al. (2007) The 1.6 Å crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis. J Mol Biol 366, 540-550.
72. Priest, F.G., Barker, M., Baillie, L.W.J., Holmes, E.C. and Maiden, M.C.J. (2004) Population structure and evolution of the Bacillus cereus group. J Bacteriol 186, 7959-7970.
73. Ramesh, V., Fralick, J.A. and Rolfe, R.D. (1999) Prevention of Clostridium difficile-induced ileocecitis with bacteriophage. Anaerobe 5, 69-78.
74. Rasko, D.A., Altherr, M.R., Han, C.S. and Ravel, J. (2005) Genomics of the Bacillus cereus group of organisms. FEMS Microbiol Rev 29, 303-329.
75. Reid, C.W., Vinogradov, E., Li, J., Jarrell, H.C., Logan, S.M. and Brisson, J.R. (2012) Structural characterization of surface glycans from Clostridium difficile. Carbohydr Res 354, 65-73.
76. Roberts, S.B., Gowen, C.M., Brooks, J.P. and Fong, S.S. (2010) Genome-scale metabolic analysis of Clostridium thermocellum for bioethanol production. BMC Syst Biol 4, 31.
77. Schmelcher, M., Donovan, D.M. and Loessner, M.J. (2012) Bacteriophage endolysins as novel antimicrobials. Future Microbiol 7, 1147-1171.
78. Schmelcher, M., Shen, Y., Nelson, D.C., Eugster, M.R., Eichenseher, F., Hanke, D.C., Loessner, M.J., Dong, S. et al. (2015) Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection. J Antimicrob Chemother 70, 1453-1465.
79. Schofield, D.A., Sharp, N.J., Vandamm, J., Molineux, I.J., Spreng, K.A., Rajanna, C., Westwater, C. and Stewart, G.C. (2013) Bacillus anthracis diagnostic detection and rapid antibiotic susceptibility determination using 'bioluminescent' reporter phage. J Microbiol Methods 95, 156-161.
80. Schuch, R., Nelson, D. and Fischetti, V.A. (2002) A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884-889.
81. Seal, B.S. (2013) Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacterium1. Poult Sci 92, 526-533.
82. Seelert, T., Ghosh, D. and Yargeau, V. (2015) Improving biohydrogen production using Clostridium beijerinckii immobilized with magnetite nanoparticles. Appl Microbiol Biotechnol 99, 4107-4116.
83. Sekulovic, O., Garneau, J.R., Néron, A. and Fortier, L.-C. (2014) Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins. Appl Environ Microbiol 80, 2555-2563.
84. Setlow, B., Parish, S., Zhang, P., Li, Y.Q., Neely, W.C. and Setlow, P. (2014) Mechanism of killing of spores of Bacillus anthracis in a high-temperature gas environment, and analysis of DNA damage generated by various decontamination treatments of spores of Bacillus anthracis, Bacillus subtilis and Bacillus thuringiensis. J Appl Microbiol 116, 805-814.
85. Shin, H., Lee, J.-H., Park, J., Heu, S. and Ryu, S. (2014) Characterization and genome analysis of the Bacillus cereus-infecting bacteriophages BPS10C and BPS13. Arch Virol 159, 2171-2175.
86. Son, B., Yun, J., Lim, J.A., Shin, H., Heu, S. and Ryu, S. (2012) Characterization of LysB4, an endolysin from the Bacillus cereus-infecting bacteriophage B4. BMC Microbiol 12, 33.
87. Sozhamannan, S., Mckinstry, M., Lentz, S.M., Jalasvuori, M., Mcafee, F., Smith, A., Dabbs, J., Ackermann, H.-W. et al. (2008) Molecular characterization of a variant of Bacillus anthracis-specific phage AP50 with improved bacteriolytic activity. Appl Environ Microbiol 74, 6792-6796.
88. Stern, A. and Sorek, R. (2011) The phage-host arms race: shaping the evolution of microbes. BioEssays 33, 43-51.
89. Sulakvelidze, A., Alavidze, Z. and Morris, J.G. (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45, 649-659.
90. Verbeken, G., Pirnay, J.-P., Lavigne, R., Jennes, S., De Vos, D., Casteels, M. and Huys, I. (2014) Call for a dedicated european legal framework for bacteriophage therapy. Arch Immun Ter Exp 62, 117-129.
91. Volozhantsev, N.V., Verevkin, V.V., Bannov, V.A., Krasilnikova, V.M., Myakinina, V.P., Zhilenkov, E.L., Svetoch, E.A., Stern, N.J. et al. (2011) The genome sequence and proteome of bacteriophage PhiCPV1 virulent for Clostridium perfringens. Virus Res 155, 433-439.
92. Volozhantsev, N.V., Oakley, B.B., Morales, C.A., Verevkin, V.V., Bannov, V.A., Krasilnikova, V.M., Popova, A.V., Zhilenkov, E.L. et al. (2012) Molecular characterization of podoviral bacteriophages virulent for Clostridium perfringens and their comparison with members of the Picovirinae. PLoS ONE 7, e38283.
93. Walmagh, M., Boczkowska, B., Grymonprez, B., Briers, Y., Drulis-Kawa, Z. and Lavigne, R. (2013) Characterization of five novel endolysins from gram-negative infecting bacteriophages. Appl Microbiol Biotechnol 97, 4369-4375.
94. Westra, E.R., Swarts, D.C., Staals, R.H., Jore, M.M., Brouns, S.J. and van der Oost, J. (2012) The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity. Annu Rev Gene 46, 311-339.
95. Yang, H., Wang, D.-B., Dong, Q., Zhang, Z., Cui, Z., Deng, J., Yu, J., Zhang, X.-E. et al. (2012) Existence of separate domains in lysin PlyG for recognizing Bacillus anthracis spores and vegetative cells. Antimicrob Agents Chemother 56, 5031-5039.
96. Yang, H., Zhang, Y., Yu, J., Huang, Y., Zhang, X.E. and Wei, H. (2014) Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Chemother 58, 536-542.
97. Yoong, P., Schuch, R., Nelson, D. and Fischetti, V.A. (2006) PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. J Bacteriol 188, 2711-2714.
98. Yuan, Y., Peng, Q. and Gao, M. (2012a) Characteristics of a broad lytic spectrum endolysin from phage BtCS33 of Bacillus thuringiensis. BMC Microbiol 12, 297.
99. Yuan, Y.H., Gao, M.Y., Wu, D.D., Liu, P.M. and Wu, Y. (2012b) Genome characteristics of a novel phage from Bacillus thuringiensis showing high similarity with phage from Bacillus cereus. PLoS ONE 7, e37557.
100. Zaczek, M., Weber-Dabrowska, B. and Górski, A. (2015) Phages in the global fruit and vegetable industry. J Appl Microbiol 118, 537-556.
101. Zimmer, M., Scherer, S. and Loessner, M.J. (2002) Genomic analysis of Clostridium perfringens bacteriophage ϕ3626, which integrates into guaA and possibly affects sporulation. J Bacteriol 184, 4359-4368.